Characterization of serosal bridges: routes for antigen and pathogen transport from the female reproductive tract to the intestines.

Information

  • Research Project
  • 9491678
  • ApplicationId
    9491678
  • Core Project Number
    R21AI133062
  • Full Project Number
    5R21AI133062-02
  • Serial Number
    133062
  • FOA Number
    PA-16-161
  • Sub Project Id
  • Project Start Date
    6/1/2017 - 7 years ago
  • Project End Date
    5/31/2019 - 5 years ago
  • Program Officer Name
    HILTKE, THOMAS J
  • Budget Start Date
    6/1/2018 - 6 years ago
  • Budget End Date
    5/31/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    02
  • Suffix
  • Award Notice Date
    5/22/2018 - 6 years ago

Characterization of serosal bridges: routes for antigen and pathogen transport from the female reproductive tract to the intestines.

PROJECT SUMMARY/ABSTRACT In this application the researchers propose to 1) characterize ?serosal bridges? (SBs), a previously unknown internal route that facilitates antigen and cell transport between the female reproductive tract (FRT) and the gastro-intestinal (GI) tract; and 2) assess the essentiality of SBs and cell migration for transport of Chlamydia spp. from the FRT to the GI tract. The team showed that vaginal immunization with ovalbumin-conjugated 20 nm nanoparticles (NPs) induces serum IgG and primes the intestinal mucosa for secretion of IgA. Surprisingly, it was found that vaginally-instilled soluble antigens and NPs are ?delivered? to the lower stomach and duodenum. Moreover, vaginally-instilled Chlamydia spp. elementary bodies (300-450 nm) reach SBs and intestinal serosa within 1-3 hours. In humans and animals Chlamydia spp. spreads from the FRT and persists in the GI tract, where it is resistant to azithromycin treatment. In mice, Chlamydia disseminates internally however, how it transits from the FRT to the GI tract remains unknown. Completion of the proposed work will be critical for understanding dissemination of Chlamydia from the FRT to the GI tract, as well as for developing vaccination strategies to target this pathogen.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    125000
  • Indirect Cost Amount
    59375
  • Total Cost
    184375
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIAID:184375\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SOUTHERN ILLINOIS UNIVERSITY CARBONDALE
  • Organization Department
    MICROBIOLOGY/IMMUN/VIROLOGY
  • Organization DUNS
    939007555
  • Organization City
    CARBONDALE
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    629014709
  • Organization District
    UNITED STATES